Creekmur Asset Management LLC Cuts Stock Position in Aflac Incorporated (NYSE:AFL)

Creekmur Asset Management LLC reduced its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 33.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,722 shares of the financial services provider's stock after selling 5,899 shares during the period. Creekmur Asset Management LLC's holdings in Aflac were worth $1,303,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of AFL. Valued Wealth Advisors LLC raised its holdings in Aflac by 24.4% in the 1st quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider's stock valued at $55,000 after buying an additional 97 shares during the last quarter. Phillips Wealth Planners LLC boosted its holdings in Aflac by 1.5% during the 1st quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider's stock worth $711,000 after acquiring an additional 100 shares during the last quarter. Optas LLC boosted its holdings in Aflac by 3.5% during the 1st quarter. Optas LLC now owns 2,949 shares of the financial services provider's stock worth $328,000 after acquiring an additional 101 shares during the last quarter. Family Legacy Inc. boosted its holdings in shares of Aflac by 4.3% in the 4th quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider's stock worth $270,000 after buying an additional 107 shares during the last quarter. Finally, Titleist Asset Management LLC raised its stake in Aflac by 3.4% in the 4th quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider's stock valued at $344,000 after acquiring an additional 110 shares during the period. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

AFL has been the topic of several research analyst reports. Wells Fargo & Company set a $105.00 price objective on shares of Aflac and gave the stock an "equal weight" rating in a research report on Thursday, July 10th. Wall Street Zen cut Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. Barclays set a $98.00 target price on Aflac and gave the company an "underweight" rating in a research note on Monday, July 7th. Raymond James Financial dropped their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Finally, Morgan Stanley boosted their price objective on Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Aflac presently has an average rating of "Hold" and a consensus price target of $107.07.

Aflac Stock Up 0.2%

Shares of AFL stock traded up $0.19 during trading hours on Monday, reaching $102.02. 269,696 shares of the company's stock were exchanged, compared to its average volume of 2,145,771. Aflac Incorporated has a 1 year low of $93.00 and a 1 year high of $115.50. The stock has a market cap of $55.16 billion, a PE ratio of 15.94, a PEG ratio of 3.15 and a beta of 0.81. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. The stock's fifty day moving average price is $103.33 and its two-hundred day moving average price is $105.20.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a return on equity of 15.55% and a net margin of 21.27%. The business had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $4.53 billion. During the same quarter in the previous year, the firm posted $1.66 EPS. Aflac's revenue was down 37.5% on a year-over-year basis. Research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were issued a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's payout ratio is presently 36.25%.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the sale, the director directly owned 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This trade represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Masatoshi Koide sold 37,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director directly owned 70,992 shares in the company, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,750 shares of company stock valued at $4,304,295. 0.80% of the stock is owned by company insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.